Expand GERN Menu
GERN MENU

GERN Latest Press Releases

-- December 13, 2024 --

Geron Announces Positive CHMP Opinion for RYTELO (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS Business Wire 6:36 AM

-- December 10, 2024 --

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies Business Wire 9:00 AM
Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis Business Wire 9:00 AM

-- November 27, 2024 --

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference Business Wire 9:00 AM

-- November 21, 2024 --

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- November 11, 2024 --

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development Business Wire 4:30 PM
Geron to Participate in the Stifel 2024 Healthcare Conference Business Wire 9:00 AM

-- November 7, 2024 --

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million Globe Newswire 7:10 AM
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors Business Wire 7:01 AM
Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights Business Wire 7:00 AM

-- November 5, 2024 --

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO (imetelstat) in Myeloid Hematologic Malignancies Business Wire 9:00 AM

-- October 17, 2024 --

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- October 15, 2024 --

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024 Business Wire 4:30 PM

-- September 19, 2024 --

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- September 9, 2024 --

Geron Corporation Announces Appointment of Jim Ziegler as Chief Commercial Officer Business Wire 4:15 PM

-- August 22, 2024 --

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- August 8, 2024 --

Geron Corporation Reports Second Quarter 2024 Financial Results and Business Highlights Business Wire 7:00 AM

-- July 26, 2024 --

Geron Announces Updated NCCN Guidelines Recommending RYTELO (imetelstat) for the Treatment of Symptomatic Anemia in Patients with Lower-Risk MDS Business Wire 7:30 AM

-- July 23, 2024 --

Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024 Business Wire 4:15 PM

-- July 18, 2024 --

Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024 Business Wire 4:30 PM